MNG Laboratories is Now Offering Enhanced Ataxia Panels
April 26, 2017
Our Ataxia Panel Portfolio
MNG Laboratories has expanded our Ataxia/Episodic Ataxia testing to include sequencing of 330 genes
with copy number analysis, mtDNA sequencing & deletion, and most notably, the Spinocerebellar Ataxia (SCA) repeat expansions
. Not only is our core panel improved and broadened; we’ve also included the repeat expansions necessary to enhance the diagnostic power of our targeted Ataxia panels.
Approximately 50-80% of ataxia cases are caused by repeat expansions which are not detected by standard sequencing methods. Thus, panels that do not include these add-ons are more likely to be negative. In order to offer our clients the most sensitive testing options in a comprehensive Ataxia panel, we have expanded our panel offerings to include repeat expansions that target the most common causes of these disorders.
Our testing options now include:
SCA Repeat expansions include SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, & DRPLA.